Below are the financial statements of Gilead Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Product sales | 28,610a | 26,934a | 26,982a |
| Royalty, contract and other revenues | 144a | 182a | 299a |
| Total revenues | 28,754a | 27,116a | 27,281a |
| Costs and expenses | — | — | — |
| Cost of goods sold | -6,251a | -6,498a | -5,657a |
| Research and development expenses | -5,907a | -5,718a | -4,977a |
| Acquired in-process research and development expenses | -4,663a | -1,155a | -944a |
| In-process research and development impairments | -4,180a | -50a | -2,700a |
| Selling, general and administrative expenses | -6,091a | -6,090a | -5,673a |
| Total costs and expenses | -27,092a | -19,511a | -19,951a |
| Operating income | 1,662a | 7,605a | 7,330a |
| Interest expense | -977a | -944a | -935a |
| Other (income) expense, net | -6a | -198a | 581a |
| Income before income taxes | 690a | 6,859a | 5,814a |
| Income tax expense | -211a | -1,247a | -1,248a |
| Net income | 480a | 5,613a | 4,566a |
| Net loss attributable to noncontrolling interest | 0a | -52a | -26a |
| Net income attributable to Gilead | 480a | 5,665a | 4,592a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gilead Sciences’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.